Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. | 24058443 | Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Lacroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, … | PLoS ONE | 2013 | PLCO |
| Genome-wide association study identifies two susceptibility loci for osteosarcoma. | 23727862 | Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Kurucu N, Ilhan IE, Sari N, Serra M, Hattinger C, Picci P, Spector LG, … | Nat. Genet. | 2013 | PLCO |
| A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. | 23814017 | Purdue MP, Hofmann JN, Kemp TJ, Chaturvedi AK, Lan Q, Park JH, Pfeiffer RM, Hildesheim A, Pinto LA, Rothman N | Blood | 2013 | PLCO |
| Circulating inflammation markers and prospective risk for lung cancer. | 24249745 | Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK | J. Natl. Cancer Inst. | 2013 | PLCO |
| Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. | 23903690 | Safaeian M, Rajaraman P, Hartge P, Yeager M, Linet M, Butler MA, Ruder AM, Purdue MP, Hsing A, Beane-Freeman L, Hoppin JA, Albanes D, Weinstein SJ, Inskip PD, Brenner A, Rothman N, Chatterjee N, Gillanders EM, Chanock SJ, Wang SS | Cancer Causes Control | 2013 | PLCO |
| Hormonal risk factors and invasive epithelial ovarian cancer risk by parity. | 23820255 | Bodelon C, Wentzensen N, Schonfeld SJ, Visvanathan K, Hartge P, Park Y, Pfeiffer RM | Br. J. Cancer | 2013 | PLCO |
| Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. | 23396963 | Sampson JN, Boca SM, Shu XO, Stolzenberg-Solomon RZ, Matthews CE, Hsing AW, Tan YT, Ji BT, Chow WH, Cai Q, Liu DK, Yang G, Xiang YB, Zheng W, Sinha R, Cross AJ, Moore SC | Cancer Epidemiol. Biomarkers Prev. | 2013 | PLCO |
| Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. | 23115063 | Melin B, Dahlin AM, Andersson U, Wang Z, Henriksson R, Hallmans G, Bondy ML, Johansen C, Feychting M, Ahlbom A, Kitahara CM, Wang SS, Ruder AM, Carreón T, Butler MA, Inskip PD, Purdue M, Hsing AW, Mechanic L, Gillanders E, Yeager M, Linet M, Chanock… | Int. J. Cancer | 2013 | PLCO |
| Fruit and vegetable intake and risk of breast cancer by hormone receptor status. | 23349252 | Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML… | J. Natl. Cancer Inst. | 2013 | PLCO |
| A prospective study of leukocyte telomere length and risk of renal cell carcinoma. | 23513041 | Hofmann JN, Lan Q, Cawthon R, Hosgood HD, Shuch B, Moore LE, Rothman N, Chow WH, Purdue MP | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2013 | PLCO |
| Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 23698636 | Koutros S, Meyer TE, Fox SD, Issaq HJ, Veenstra TD, Huang WY, Yu K, Albanes D, Chu LW, Andriole G, Hoover RN, Hsing AW, Berndt SI | Carcinogenesis | 2013 | PLCO |
| Long-term mortality after screening for colorectal cancer. | 24047060 | Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR | N Engl J Med | 2013 | MINN |
| Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk. | 23951112 | Corral R, Lewinger JP, Joshi AD, Levine AJ, Vandenberg DJ, Haile RW, Stern MC | PLoS One | 2013 | PLCO |
| Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. | 22546513 | Lavender NA, Rogers EN, Yeyeodu S, Rudd J, Hu T, Zhang J, Brock GN, Kimbro KS, Moore JH, Hein DW, Kidd LC | BMC Med Genomics | 2012 | PLCO |
| Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 22429766 | Sutcliffe S, Grubb Iii RL, Platz EA, Ragard LR, Riley TL, Kazin SS, Hayes RB, Hsing AW, Andriole GL, Urologic Diseases in America Project | BJU Int. | 2012 | PLCO |
| Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. | 22162237 | Anderson KE, Mongin SJ, Sinha R, Stolzenberg-Solomon R, Gross MD, Ziegler RG, Mabie JE, Risch A, Kazin SS, Church TR | Mol. Carcinog. | 2012 | PLCO |
| Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. | 21932422 | Gao Y, Katki H, Graubard B, Pollak M, Martin M, Tao Y, Schoen RE, Church T, Hayes RB, Greene MH, Berndt SI | Int. J. Cancer | 2012 | PLCO |
| Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. | 22228146 | Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan… | J. Natl. Cancer Inst. | 2012 | PLCO |
| Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer. | 22198243 | Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, Buys SS | Gynecol. Oncol. | 2012 | PLCO |
| Tracking and tracing of participants in two large cancer screening trials. | 22561392 | Marcus PM, Childs J, Gahagan B, Gren LH | Contemp Clin Trials | 2012 | NLST, PLCO |